Literature DB >> 12871301

Integrins, cations and ligands: making the connection.

J-P Xiong1, T Stehle, S L Goodman, M A Arnaout.   

Abstract

Integrins are cell adhesion receptors that couple extracellular divalent cation-dependent recognition events with intracellular mechanical and biochemical responses and vice versa, thus affecting every function of nucleated cells. The structural basis of this bidirectional signaling and its dependency on cations has been the focus of intensive study over the past three decades. Significant progress made recently in elucidating the three-dimensional structure of the extracellular and cytoplasmic segments of integrins is giving valuable new insights into the tertiary and quaternary changes that underlie activation, ligand recognition and signaling by these receptors.

Mesh:

Substances:

Year:  2003        PMID: 12871301     DOI: 10.1046/j.1538-7836.2003.00277.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  12 in total

Review 1.  The regulation of integrin function by divalent cations.

Authors:  Kun Zhang; JianFeng Chen
Journal:  Cell Adh Migr       Date:  2012 Jan-Feb       Impact factor: 3.405

Review 2.  The endothelial glycocalyx: composition, functions, and visualization.

Authors:  Sietze Reitsma; Dick W Slaaf; Hans Vink; Marc A M J van Zandvoort; Mirjam G A oude Egbrink
Journal:  Pflugers Arch       Date:  2007-01-26       Impact factor: 3.657

3.  Antagonistic VEGF variants engineered to simultaneously bind to and inhibit VEGFR2 and alphavbeta3 integrin.

Authors:  Niv Papo; Adam P Silverman; Jennifer L Lahti; Jennifer R Cochran
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-08       Impact factor: 11.205

4.  Isolation and Functional Identification of an Antiplatelet RGD-Containing Disintegrin from Cerastes cerastes Venom.

Authors:  Meriem Ameziani; Fatah Chérifi; Hamida Kiheli; Samah Saoud; Ghania Hariti; Safia Kellou-Taîri; Fatima Laraba-Djebari
Journal:  Protein J       Date:  2020-09-22       Impact factor: 2.371

5.  N-terminus 4-Chloromethyl Thiazole Peptide as a Macrocyclization Tool in the Synthesis of Cyclic Peptides: Application to the Synthesis of Conformationally Constrained RGD-Containing Integrin Ligands.

Authors:  Adel Nefzi; Jason E Fenwick
Journal:  Tetrahedron Lett       Date:  2011-02-16       Impact factor: 2.415

6.  Targeting activated integrin alphavbeta3 with patient-derived antibodies impacts late-stage multiorgan metastasis.

Authors:  Karin Staflin; Joseph S Krueger; Janna Hachmann; Jane S Forsyth; Mihaela Lorger; Sebastian C J Steiniger; Jenny Mee; Cristina Pop; Guy S Salvesen; Kim D Janda; Brunhilde Felding-Habermann
Journal:  Clin Exp Metastasis       Date:  2010-03-12       Impact factor: 5.150

7.  Breast adenocarcinoma cell adhesion to the vascular subendothelium in whole blood and under flow conditions: effects of alphavbeta3 and alphaIIbbeta3 antagonists.

Authors:  Noëlia Gomes; Jany Vassy; Claude Lebos; Brigitte Arbeille; Chantal Legrand; Françoise Fauvel-Lafeve
Journal:  Clin Exp Metastasis       Date:  2004       Impact factor: 5.150

8.  Combinatorial antibody libraries from cancer patients yield ligand-mimetic Arg-Gly-Asp-containing immunoglobulins that inhibit breast cancer metastasis.

Authors:  Brunhilde Felding-Habermann; Richard A Lerner; Antonietta Lillo; Shufei Zhuang; Martin R Weber; Sandra Arrues; Changshou Gao; Shenlan Mao; Alan Saven; Kim D Janda
Journal:  Proc Natl Acad Sci U S A       Date:  2004-11-24       Impact factor: 11.205

9.  A Lupus-Associated Mac-1 Variant Has Defects in Integrin Allostery and Interaction with Ligands under Force.

Authors:  Florencia Rosetti; Yunfeng Chen; Mehmet Sen; Elizabeth Thayer; Veronica Azcutia; Jan M Herter; F William Luscinskas; Xavier Cullere; Cheng Zhu; Tanya N Mayadas
Journal:  Cell Rep       Date:  2015-03-12       Impact factor: 9.423

10.  Plasminogen activator inhibitors regulate cell adhesion through a uPAR-dependent mechanism.

Authors:  Ralf-Peter Czekay; David J Loskutoff
Journal:  J Cell Physiol       Date:  2009-09       Impact factor: 6.384

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.